ENHANCE and ACCORD: controversy over surrogate end points

Curr Cardiol Rep. 2008 May;10(3):159-61. doi: 10.1007/s11886-008-0027-z.
No abstract available

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Azetidines / therapeutic use
  • Biomarkers*
  • Clinical Trials as Topic*
  • Clinical Trials, Phase IV as Topic
  • Endpoint Determination*
  • Ezetimibe
  • Glycated Hemoglobin A / metabolism
  • Humans
  • Hypercholesterolemia / drug therapy
  • Research Design*
  • Simvastatin / therapeutic use

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Biomarkers
  • Glycated Hemoglobin A
  • Simvastatin
  • Ezetimibe